The global Cancer Biomarkers Market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the ... Read more

The cancer biomarkers market is estimated to be valued at US$ 380.84 Bn in 2023 and is expected to exhibit a CAGR of 14. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Cancer biomarkers are biological molecules found in blood, urine, other body fluids or tissues that are indicators of normal or abnormal biological processes, pathogenic processes, or ... Read more